Abstract:Zhipeng Wu, 1, &ast Zujin Luo, 2, &ast Zengtao Luo, 2 Jingyi Ge, 3 Jiawei Jin, 4 Zhixin Cao, 2 Yingmin Ma 1 1 Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China; 3 Department of Respiratory Medicine, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, People's Republic of China; 4 The Clinical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingmin Ma, Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China, Tel +86 10-13501185982, Email Purpose: The evidence of long-term home noninvasive positive pressure ventilation (LTHNIPPV) in patients with stable hypercapnic chronic obstructive pulmonary disease (COPD) is controversial. In this meta-analysis study, we sought to establish whether a baseline level and reduction in partial pressure of arterial carbon dioxide (PaCO2) were associated with the treatment effect of LTHNIPPV in these patients. Patients and Methods: Six electronic databases were comprehensively searched from January 1980 until June 2020. Randomized clinical trials (RCTs) comparing LTHNIPPV with control treatment were included. Two authors independently extracted data, assessed the study quality, and used the GRADE approach to evaluate evidence quality. The main outcome was mortality. Results: Nineteen studies involving 1482 patients (LTHNIPPV, n = 730; control, n = 752) were included. LTHNIPPV significantly reduced mortality (relative risk [RR] = 0.76; 95% confidence interval [CI]: 0.61– 0.95; p = 0.02; I 2 = 14%), the frequency of hospital admissions, PaCO2, and improved partial pressure of oxygen (PaO2) compared to control treatment. LTHNIPPV also relieved dyspnea and improved exercise capacity and health-related quality of life (HRQL) but showed no significant benefit for improving the forced expiratory volume in one second in predicted (FEV1% pred). Subgroup analysis revealed that the baseline level and reduction in PaCO2 were associated with decreased mortality (baseline PaCO2 ≥ 55 mmHg RR = 0.69, P = 0.02; vs baseline PaCO2 < 55 mmHg RR = 0.87, P = 0.32; and higher dPaCO2 RR = 0.42, P < 0.0001; vs lower dPaCO2 RR = 0.91, P = 0.38). Conclusion: LTHNIPPV significantly reduced mortality. The baseline level and reduction in PaCO2 were associated with the treatment effect of LTHNIPPV in patients with stable hypercapnic COPD. Large-scale, multicenter RCTs are needed to confirm our results. Keywords: COPD, long-term home noninvasive positive pressure ventilation, mortality, meta-analysis study, RCTs, stable hypercapnic Chronic obstructive pulmonary disease (COPD) is a common disease with nonreversible airflow limitation and persistent respiratory symptoms, such as cough. COPD is a primary cause of morbidity and mortality worldwide and represents a great social and economic burden for humans. 1–3 Noninvasive positive pressure ventilation (NIPPV) is recommended as the first ventilation method for patients with COPD with acute exacerbation, but for stable patients with COPD, the evidence is still controversial. 4,5 The latest GOLD guideline (2019) reported that the evidence for regular use of long-term home NIPPV (LTHNIPPV) in stable COPD patients remains insufficient. However, the guideline also emphasized that LTHNIPPV can probably be used in patients with daytime hypercapnia. 1 Studies have found that patients with stable hypercapnia have poor prognosis compared to those with normocapnia and reversible hypercapnic COPD. 6–11 Randomized clinical trials (RCTs) comparing LTHNIPPV with control treatment in patients with stable hypercapnic COPD have been conducted. 12–18 Köhnlein et al 13 found that LTHNIPPV could reduce mortality, but Murphy et al 18 found that the mortality rate was not significantly different between the LTHNIPPV group and the control group. Previous meta-analysis studies combined these RCTs and showed that LTHNIPPV reduced PaCO2 but did not decrease all-cause mortality or improve PaO2 compared to control treatment for patients with stable hypercapnic COPD. 19–22 The most recent meta-analysis study combined RCTs and observational studies and found that LTHNIPPV reduced all-cause mortality c -Abstract Truncated-

PaCO2 six months after the initiation of long-term noninvasive ventilation in patients with COPD

Efficacy and Impact on Serum Matrix Metalloproteinase-9 of Long-Term Non-Invasive Positive Pressure Ventilation Combined with Inhaling Corticosteroids in Patients with Stable Severe Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

[The Efficacy and Safety of Long Term Home Noninvasive Positive Pressure Ventilation in Patients with Stable Severe Chronic Obstructive Pulmonary Disease].

Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial

Does PaCO2 correction have an impact on survival of patients with chronic respiratory failure and long-term non-invasive ventilation?

Baseline Level and Reduction in PaCO2 are Associated with the Treatment Effect of Long-Term Home Noninvasive Positive Pressure Ventilation in Stable Hypercapnic Patients with COPD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The appropriate setting of noninvasive pressure support ventilation in stable COPD patients

[Prospective Randomized Controlled Clinical Study of Early Use of Noninvasive Positive Pressure Ventilation in the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

Home Noninvasive Positive Pressure Ventilation With Built-In Software In Stable Hypercapnic Copd: A Short-Term Prospective, Multicenter, Randomized, Controlled Trial

The Clinical Value of Noninvasive Ventilation in Chronic Hypercapnic Respiratory Failure--a 3-Year Retrospective Study

Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome

Patient Outcome after Chronic Obstructive Pulmonary Disease Exacerbations Requiring Non-invasive Ventilation during Hospitalization

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure

Home noninvasive ventilation in severe COPD: in whom does it work and how?

Optimal Time of the Use of Non-Invasive Positive Pressure Ventilation on Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Respiratory Failure

PaCO2 is nonlinearly associated with NIV failure in patients with hypoxemic respiratory failure

[Application of capnography and SpO2 measurement in the evaluation of respiratory failure in patients with chronic obstructive pulmonary disease]

[Home non-invasive ventilation for chronic obstructive pulmonary disease]

Day-to-Day Variability of Parameters Recorded by Home Noninvasive Positive Pressure Ventilation for Detection of Severe Acute Exacerbations in COPD.

A simple model for home initiation of Long-term non-invasive ventilation for treatment of respiratory failure in COPD - a Danish clinical experience